Finance

Lists
006620:KOSDAQ
DongKoo Bio & Pharma Co Ltd
â‚©3,485.00
+0.14%
(+5.00) 1D
Oct 19, 3:30:09 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 006620...
Open
â‚©3,450
High
â‚©3,535
Low
â‚©3,440
Mkt. cap
99.20B
Avg. vol.
53.16K
Volume
21.26K
Dividend
3.44%
Quarterly dividend
â‚©30
Ex-dividend date
Dec 27, 2024
P/E ratio
2.85
52-wk high
â‚©6,300
52-wk low
â‚©3,280
EPS
â‚©1,221
Shares outstanding
28.46M
No. of employees
383
Open
â‚©3,450
High
â‚©3,535
Low
â‚©3,440
Mkt. cap
99.20B
Avg. vol.
53.16K
Volume
21.26K
Dividend
3.44%
Quarterly dividend
â‚©30
Ex-dividend date
Dec 27, 2024
P/E ratio
2.85
52-wk high
â‚©6,300
52-wk low
â‚©3,280
EPS
â‚©1,221
Shares outstanding
28.46M
No. of employees
383
News stories
From web sources and news partners
About DongKoo Bio & Pharma Co Ltd
CEO-
Employees383
Founded1970
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
62.02B
61.87B
58.06B
59.48B
Cost of goods sold
25.77B
26.33B
23.46B
26.14B
Cost of revenue
25.77B
26.33B
23.46B
26.14B
Research and development expenses
2.45B
3.14B
2.89B
2.18B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.30B
29.21B
29.59B
37.28B
Operating expense
34.06B
32.74B
32.80B
39.78B
Total operating expenses
59.83B
59.08B
56.26B
65.93B
Operating income
2.19B
2.80B
1.81B
-6.45B
Other non operating income
8.94M
17.20B
-4.35B
6.24B
EBT including unusual items
-1.04B
51.54B
-599.20M
-6.96B
EBT excluding unusual items
1.29B
19.20B
-3.32B
-1.14B
Income tax expense
584.39M
10.31B
-21.28M
-822.61M
Effective tax rate
-56.25%
20.01%
3.55%
11.81%
Other operating expenses
59.89M
47.24M
123.62M
73.88M
Net income
-1.62B
41.27B
-577.35M
-6.07B
Net profit margin
-2.60%
66.71%
-0.99%
-10.20%
Earnings per share
-
-
-
-
Interest and investment income
20.90M
28.15M
63.80M
100.72M
Interest expense
-947.86M
-802.30M
-1.01B
-1.06B
Net interest expenses
-926.96M
-774.15M
-947.00M
-954.50M
Depreciation and amortization charges
165.96M
208.57M
214.31M
223.05M
EBITDA
4.41B
4.98B
3.75B
-4.52B
Gain or loss from assets sale
-
-3.63M
-16.46M
1.00K
AI content may include mistakes. Learn more
Google apps